FI49024C - A process for the preparation of basically substituted amides of therapeutically active N-substituted anthralic acids and their salts. - Google Patents

A process for the preparation of basically substituted amides of therapeutically active N-substituted anthralic acids and their salts.

Info

Publication number
FI49024C
FI49024C FI191768A FI191768A FI49024C FI 49024 C FI49024 C FI 49024C FI 191768 A FI191768 A FI 191768A FI 191768 A FI191768 A FI 191768A FI 49024 C FI49024 C FI 49024C
Authority
FI
Finland
Prior art keywords
substituted
anthralic
salts
acids
preparation
Prior art date
Application number
FI191768A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI49024B (en
Inventor
Boerge Alhede
Karl Neuhold
Original Assignee
Gea As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea As filed Critical Gea As
Publication of FI49024B publication Critical patent/FI49024B/fi
Application granted granted Critical
Publication of FI49024C publication Critical patent/FI49024C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI191768A 1967-07-03 1968-07-03 A process for the preparation of basically substituted amides of therapeutically active N-substituted anthralic acids and their salts. FI49024C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK342267A DK121236B (en) 1967-07-03 1967-07-03 Analogous process for the preparation of therapeutically active, basic substituted amides of N-substituted anthranilic acids, or acid addition salts thereof.

Publications (2)

Publication Number Publication Date
FI49024B FI49024B (en) 1974-12-02
FI49024C true FI49024C (en) 1975-03-10

Family

ID=8122684

Family Applications (1)

Application Number Title Priority Date Filing Date
FI191768A FI49024C (en) 1967-07-03 1968-07-03 A process for the preparation of basically substituted amides of therapeutically active N-substituted anthralic acids and their salts.

Country Status (13)

Country Link
BE (1) BE717543A (en)
BR (1) BR6800332D0 (en)
CA (1) CA921051A (en)
CH (1) CH512436A (en)
DK (1) DK121236B (en)
ES (1) ES355674A1 (en)
FI (1) FI49024C (en)
FR (1) FR1584334A (en)
GB (1) GB1165300A (en)
IE (1) IE32158B1 (en)
NL (1) NL163503C (en)
NO (1) NO121213B (en)
SE (1) SE363504B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
PL2084132T3 (en) * 2006-09-03 2019-03-29 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
AU2007354632B2 (en) * 2007-06-04 2014-06-26 Techfields Inc Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses
MX362949B (en) 2008-12-04 2019-02-27 Yu Chongxi High penetration compositions and their applications.
CA3189252A1 (en) 2012-05-16 2013-11-21 Techfields Pharma Co., Ltd. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
JP6153264B2 (en) * 2015-01-05 2017-06-28 テックフィールズ インコーポレイテッド NSAIA prodrug with very fast skin and membrane permeation rate and novel pharmaceutical use thereof

Also Published As

Publication number Publication date
FI49024B (en) 1974-12-02
BE717543A (en) 1968-12-16
IE32158B1 (en) 1973-05-02
CH512436A (en) 1971-09-15
NO121213B (en) 1971-02-01
GB1165300A (en) 1969-09-24
IE32158L (en) 1969-01-03
NL6809321A (en) 1969-01-07
CA921051A (en) 1973-02-13
SE363504B (en) 1974-01-21
DK121236B (en) 1971-09-27
NL163503C (en) 1980-09-15
DE1768818B2 (en) 1977-05-05
NL163503B (en) 1980-04-15
DE1768818A1 (en) 1971-12-30
ES355674A1 (en) 1970-01-01
FR1584334A (en) 1969-12-19
BR6800332D0 (en) 1973-02-13

Similar Documents

Publication Publication Date Title
FI42712C (en) Process for the preparation of therapeutically active biphenylalkane derivatives
FI48730C (en) Process for the preparation of therapeutically useful 1-aminoalkyl-substituted phthalans and isochromanes and their acid addition salts.
FI49497C (en) Process for the preparation of therapeutically active 1-phenoxy-2-3-alkylaminopropanes.
FI51936C (en) A process for the preparation of therapeutically useful 3,4-dihydronaphthalenoxyoxy-2-hydroxypropylamines and their acid addition salts.
FI50876C (en) Process for the preparation of therapeutically active N-substituted imidazoles and their salts.
FI49024C (en) A process for the preparation of basically substituted amides of therapeutically active N-substituted anthralic acids and their salts.
FI49409C (en) A process for the preparation of pharmacologically active quinuclidine-2- and quinuclidine-3-carboxylic acid anilides and their therapeutically acceptable salts.
FI41394C (en) Process for the preparation of therapeutically active N-substituted I-aminoindan derivatives
OA04038A (en) Process for the preparation of substituted phenylacetic acids and their salts.
FI45450C (en) A process for the preparation of therapeutically useful phentiazine derivatives and their salts
FI50420C (en) Process for the preparation of therapeutically active 4-pyrimidinyl-1,4-dihydropyridine derivatives
FI49413C (en) A process for the preparation of new therapeutically active phenothiazine derivatives.
FI48737C (en) A process for the preparation of antineoplastic N / N- (6-purinylthio) valeryl amino acids and their derivatives.
FI48833C (en) Process for the preparation of therapeutically useful succinic acid amides.
FI44596C (en) Process for the preparation of sulphonylurethanes and their salts
FI49021C (en) A process for the preparation of therapeutically active substituted p-alkenyloxy and p-alkynyloxyphenylacetic acids or their salts.
FI47880C (en) Process for the preparation of therapeutically active substituted phenylacetic acids
FI51813C (en) A process for the preparation of alpha-carboxypenicillin and its pharmaceutically acceptable salts.
FI52850C (en) Process for the preparation of N-substituted benzamide derivatives and their acid addition salts.
FI44229C (en) Process for the preparation of analgesic beta-unsaturated-beta-hydroxy-beta-phenylethylamines and their acid addition salts
FI44618C (en) A process for the preparation of therapeutically valuable N-substituted anthranilic acids and their salts.
FI48073C (en) A process for the preparation of therapeutically active sulfamoylanthranilic acid derivatives
FI40013C (en) A process for the preparation of therapeutically active benzoquinolizine derivatives
MY7400172A (en) Therapeutically active derivatives of n-substituted butyramide
FI41153C (en) Process for the preparation of therapeutically active N-diethylamino-ethyl-2-methoxy-4-amino-5-chlorobenzanide and its physiologically acceptable salts